EcoDrugPlus

Aldose Reductase-Like

Ensembl ID : ENSSPAG00000019151
Gene Symbol: LOC103369358
3 Cross references
345 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSSPAG00000017500
Gene Symbol: GAA
2 Cross references
233 Possible Orthologues:

Alpha-2a Adrenergic Receptor-Like

Ensembl ID : ENSSPAG00000022864
Gene Symbol: LOC103370968
3 Cross references
149 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSSPAG00000001641
Gene Symbol: LOC103357149
3 Cross references
174 Possible Orthologues:

Alpha-Synuclein-Like

Ensembl ID : ENSSPAG00000003478
Gene Symbol: LOC103368372
2 Cross references
189 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSSPAG00000005675
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amyloid Beta A4 Protein-Like

Ensembl ID : ENSSPAG00000005769
Gene Symbol: LOC103352860
3 Cross references
205 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSSPAG00000012605
Gene Symbol: APP
4 Cross references
203 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSSPAG00000014113
Gene Symbol: AR
2 Cross references
206 Possible Orthologues:

Androgen Receptor-Like

Ensembl ID : ENSSPAG00000002166
Gene Symbol: LOC103373366
2 Cross references
213 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSSPAG00000021246
Gene Symbol: AGTR1
3 Cross references
198 Possible Orthologues:

Angiotensin Ii Receptor, Type 2

Ensembl ID : ENSSPAG00000014376
Gene Symbol: AGTR2
1 Cross references
185 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).